| Literature DB >> 34507335 |
Yingwei Wang1, Junhao Wu, Lin Liu, DengSai Peng, Yue Chen.
Abstract
ABSTRACT: 68Ga-labeled quinoline-based fibroblast activation protein inhibitors (68Ga-FAPIs) are promising agents for tumor imaging. However, some nonneoplastic lesions can also cause increased FAPI uptake. We report a case of a patient with polyostotic fibrous dysplasia who showed widespread and intense metabolic activity on 68Ga-FAPI PET/CT. Physicians should be aware that fibrous dysplasia can also cause elevated FAPI activity.Entities:
Mesh：
Substances：
Year: 2022 PMID： 34507335 DOI： 10.1097/RLU.0000000000003896
Source DB: PubMed Journal: Clin Nucl Med ISSN： 0363-9762 Impact factor: 7.794